Affymetrix reports first-quarter total revenue of $80.2M Affymetrix, Inc http://www.sildenafilini.com/faq ., today reported its operating results for the first quarter of 2010. Total revenue for the quarter was $80.2 million, as compared to total revenue of $78.6 million in the first quarter of 2009.4 million, service revenue was $4.5 million, and royalties and other revenue were $2.3 million. This comes even close to first quarter 2009 product revenue of $64.9 million, program revenue of $11.6 million, and royalties and other revenue of $2.1 million.
Related Information ABC News reviews on British Prime Minister Gordon Brown’s latest commitment to expand health solutions to people in developing countries. The piece contains feedback by Lawrence Gostin, the director of the guts for Laws and the Public’s Health at Johns Hopkins and Georgetown Universities, and consultant to the WHO . Related StoriesHuman malaria parasite molecules share key gene segments with chimp, gorilla malaria parasitesTGen experts join international scientists in finding how malaria proteins could some day help stop cancerResearchers reveal why malaria vaccine provides just moderate protection among vaccinated childrenThe Informer/allAfrica.com examines the recent charm by international and Liberian non-governmental institutions to expand long-term and progressive financing for universal healthcare protection and free essential providers.